(2S,3S,4R,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 苯并咪唑核糖核苷和核糖核苷酸
• 英文名称: (2S,3S,4R,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
• 英文别名: (2S,3S,4R,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
• 化学式: C₁₂H₁₂Cl₂N₂O₄
• 分子量: 319.14
• InChiKey: XHSQDZXAVJRBMX-RHYQMDGZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  87.7
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• GUT FLORA-DERIVED EXTRACELLULAR VESICLES, AND METHOD FOR SEARCHING FOR A DISEASE MODEL, VACCINE, AND CANDIDATE DRUG AND FOR DIAGNOSIS USING SAME
  申请人：Aeon Medix Inc.

  公开号：EP2494865A2

  公开（公告）日：2012-09-05

  The present invention relates to a composition including gut flora-derived extracellular vesicles, and to an animal disease model using same. In addition, the present invention relates to a method for using the gut flora-derived extracellular vesicles to efficiently search for a candidate drug which may prevent or treat diseases that occur due to gut flora-derived extracellular vesicles, and to a vaccine which can efficiently prevent or treat infections caused by gut flora or diseases that occur due to gut flora-derived extracellular vesicles. Further, the development of diagnostic technology to discover, using the gut flora-derived extracellular vesicles of the present invention, the etiology of diseases that occur due to gut flora-derived extracellular vesicles, can be achieved.

  本发明涉及一种包括源自肠道菌群的细胞外囊泡的组合物，以及使用该组合物的动物疾病模型。此外，本发明还涉及一种使用肠道菌群衍生的胞外囊泡来有效寻找候选药物的方法，该候选药物可预防或治疗因肠道菌群衍生的胞外囊泡而发生的疾病；本发明还涉及一种疫苗，该疫苗可有效预防或治疗由肠道菌群引起的感染或因肠道菌群衍生的胞外囊泡而发生的疾病。此外，还可以开发诊断技术，利用本发明的肠道菌群源性细胞外囊泡发现因肠道菌群源性细胞外囊泡引起的疾病的病因。
• GUT FLORA-DERIVED EXTRACELLULAR VESICLES, AND METHOD FOR SEARCHING FOR A DISEASE MODEL, VACCINE, AND CANDIDATE DRUG AND FOR DIAGNOSIS USING THE SAME
  申请人：Kim Yoon Keun

  公开号：US20120222142A1

  公开（公告）日：2012-08-30

  The present application relates to a composition including gut flora-derived extracellular vesicles, and to an animal disease model using same. In addition, the present application relates to a method for using the gut flora-derived extracellular vesicles to efficiently search for a candidate drug which may prevent or treat diseases that occur due to gut flora-derived extracellular vesicles, and to a vaccine which can efficiently prevent or treat infections caused by gut flora or diseases that occur due to gut flora-derived extracellular vesicles. Further, the development of diagnostic technology to discover, using the gut flora-derived extracellular vesicles of the present application, the etiology of diseases that occur due to gut flora-derived extracellular vesicles, can be achieved.
• US9201072B2
  申请人：——

  公开号：US9201072B2

  公开（公告）日：2015-12-01
• US9274109B2
  申请人：——

  公开号：US9274109B2

  公开（公告）日：2016-03-01
• [EN] GUT FLORA-DERIVED EXTRACELLULAR VESICLES, AND METHOD FOR SEARCHING FOR A DISEASE MODEL, VACCINE, AND CANDIDATE DRUG AND FOR DIAGNOSIS USING SAME<br/>[FR] VÉSICULES EXTRACELLULAIRES DÉRIVÉES DE LA FLORE INTESTINALE, ET PROCÉDÉ DE RECHERCHE D'UN MODÈLE DE MALADIE, D'UN VACCIN ET D'UN MÉDICAMENT CANDIDAT, ET DE DIAGNOSTIC UTILISANT CE DERNIER
  申请人：AEON MEDIX INC

  公开号：WO2011027971A2

  公开（公告）日：2011-03-10

  본 발명은 장내 공생 세균(gut microbiota or gut flora)에서 유래한 세포밖 소포체를 포함하는 조성물 및 이를 이용한 질병 동물 모델에 관한 것이다. 또한 본 발명은 상기 장내 공생 세균유래 세포밖 소포체를 이용하여 장내 공생 세균유래 세포밖 소포체에 의해 발생하는 질환을 예방 또는 치료할 수 있는 후보 약물을 효율적으로 탐색하는 방법 및 장내 공생 세균에 의한 감염 또는 장내 공생 세균유래 세포밖 소포체에 의한 질병을 효율적으로 예방 또는 치료할 수 있는 백신에 관한 것이다. 이에 더하여, 본 발명의 장내 공생 세균유래 세포밖 소포체를 응용하여 장내 공생 세균유래 세포밖 소포체에 의해 발생하는 질병의 원인인자를 진단하는 기술 개발 등이 가능하다.